Navigation Links
BiOptix Participates in Leading Life Sciences Event BioWest 2012
Date:9/11/2012

BOULDER, Colo., September 11, 2012 /PRNewswire/ -- BiOptix announced continued support of the Colorado BioScience Association today, with participation in BioWest 2012, a leading life sciences showcase event in Colorado to be held at the Denver Marriott City Center.

"BiOptix continues to believe in the goals and community that is fostered by the Colorado BioScience Association, noted Rick Whitcomb, President and CEO of BiOptix.   "As Colorado continues to expand its footprint in the biosciences, BiOptix is proud to be an important part of that growth story, noted Whitcomb.

At BioWest 2012, BiOptix will highlight the upcoming 404pi, one of the most anticipated product launches in the SPR (Surface Plasmon Resonance) space.  "We are excited to launch the BiOptix 404pi, and feel that this Enhanced SPR instrument provides exceptional value and changes the game," noted Ken Wilczek, Vice President of Sales and Marketing for BiOptix.  "We have significant and building interest in the 404pi," continued Wilczek.

Features of the BiOptix 404pi include:

  • Enhanced SPR for high sensitivity
  • 4 injector / 4 flow cell design for high-throughput
  • Advanced automated fluidic system for fast kinetic measurements
  • Multiple surface chemistries
  • Compatible with industry standard Scrubber 2 software
  • Cost-effective and simple to operate

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that can measure refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix
BiOptix Diagnostics Corporation, a privately held firm based in Boulder, Colorado has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements.

Additional information about BiOptix and our products can be found at: www.bioptix.com


'/>"/>
SOURCE BiOptix
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. BiOptix announces expansion of Board of Directors
2. CNIO participates in the ENCODE project: A stride forward in biomedical research
3. Leading childhood asthma group supports federal asthma action plan to reduce disparities
4. Leading statistician receives national citation award
5. EMBO welcomes 55 leading life scientists as members
6. Putting plants online: 4 leading botanical gardens to create first online catalog of all plants
7. Worlds leading coral experts to gather in Australia
8. Leading evolutionary scientist to discuss how genome of bacteria has evolved
9. NSBRI renews space life sciences graduate programs at MIT, Texas A&M
10. First Indian-European research networking projects in the social sciences launched
11. German National Academy of Sciences issues a critical statement on the use of bioenergy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
(Date:2/22/2017)... LONDON , Feb. 22, 2017 ... by 2021, ABI Research identifies four technologies that ... solutions to secure significant share in the changing ... payments, and passive authentication.   "Companies ... it comes to security," says Dimitrios Pavlakis ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... , March 27, 2017  The global ... for 2016, according to a new report from ... lab testing is performed to evaluate disease progression, ... therapy, among other reasons.  The healthcare market research ... , provides an overview of the medical ...
(Date:3/27/2017)... ... March 27, 2017 , ... PMG Research is pleased to ... presented by The Conference Forum in Boston on April 3-4, 2017. The CTC conference ... clinical trial outcomes and bring them closer to the patient. Clinical Trial Collaborations also ...
(Date:3/27/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it is now offering a 3 ... who want to have their DarioHealth products reimbursed by ... agreements with partners across the U.S. who will be ... will supply and bill the customer,s insurance for their ...
(Date:3/24/2017)... MOSCOW and ROCKVILLE, Md. ... portfolio company of Maxwell Biotech Venture Fund (MBVF), today ... of SQ109 added to the standard drug therapy regimen ... a new small molecule drug discovered by scientists at ... US National Institutes of Health. A ...
Breaking Biology Technology: